Powered by

Boston Biomedical Celebrates 10-Year Anniversary of its Founding and Announces Appointment of Patricia S. Andrews as Chief Executive Officer

Mar 22, 2017 - PR Newswire
Board and Executive Moves

 Boston Biomedical, an industry leader in the development of next-generation cancer therapeutics designed to target cancer stemness pathways, today announced its Board of Directors has appointed Patricia S. Andrews as Chief Executive Officer, effective April 24, 2017.

Ms. Andrews will succeed Chiang J. Li, M.D., FACP, who has led Boston Biomedical since he founded the company ten years ago. Under his leadership, Boston Biomedical has grown from a "garage startup" without technology or cap

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox